IT1259419B - Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi - Google Patents

Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi

Info

Publication number
IT1259419B
IT1259419B ITMI911432A ITMI911432A IT1259419B IT 1259419 B IT1259419 B IT 1259419B IT MI911432 A ITMI911432 A IT MI911432A IT MI911432 A ITMI911432 A IT MI911432A IT 1259419 B IT1259419 B IT 1259419B
Authority
IT
Italy
Prior art keywords
unsaturated
steroids
carbose
testosterone
reductase
Prior art date
Application number
ITMI911432A
Other languages
English (en)
Inventor
Achille Panzeri
Marcella Nesi
Salle Enrico Di
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of ITMI911432A0 publication Critical patent/ITMI911432A0/it
Priority to ITMI911432A priority Critical patent/IT1259419B/it
Priority to YU52992A priority patent/YU52992A/sh
Priority to MYPI92000863A priority patent/MY131089A/en
Priority to US07/886,574 priority patent/US5212166A/en
Priority to IL10194792A priority patent/IL101947A/en
Priority to NZ242850A priority patent/NZ242850A/en
Priority to PCT/EP1992/001153 priority patent/WO1992020700A1/en
Priority to DE69221074T priority patent/DE69221074T2/de
Priority to MX9202438A priority patent/MX9202438A/es
Priority to AU17781/92A priority patent/AU655280B2/en
Priority to IDP308292A priority patent/ID954B/id
Priority to ES92910992T priority patent/ES2106185T3/es
Priority to ZA923758A priority patent/ZA923758B/xx
Priority to RU93004939A priority patent/RU2104283C1/ru
Priority to EP92108670A priority patent/EP0517047A1/en
Priority to HU9300176A priority patent/HUT64083A/hu
Priority to JP50978992A priority patent/JP3226919B2/ja
Priority to CZ93265A priority patent/CZ281309B6/cs
Priority to TW081104019A priority patent/TW213467B/zh
Priority to AT92910992T priority patent/ATE155792T1/de
Priority to EP92910992A priority patent/EP0540717B1/en
Priority to DK92910992.4T priority patent/DK0540717T3/da
Priority to CA002087953A priority patent/CA2087953A1/en
Priority to CN92103919A priority patent/CN1035055C/zh
Priority to IE163492A priority patent/IE921634A1/en
Publication of ITMI911432A1 publication Critical patent/ITMI911432A1/it
Priority to NO93930244A priority patent/NO930244L/no
Priority to FI930277A priority patent/FI930277A7/fi
Application granted granted Critical
Publication of IT1259419B publication Critical patent/IT1259419B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
  • Details Of Garments (AREA)
  • Ceramic Products (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Steroidi 3-carbossi 17 ?-sostituiti insaturi utili in stati di iperandrogenismo, processo per la loro preparazione e composizioni farmaceutiche che li contengono.
ITMI911432A 1991-05-24 1991-05-24 Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi IT1259419B (it)

Priority Applications (27)

Application Number Priority Date Filing Date Title
ITMI911432A IT1259419B (it) 1991-05-24 1991-05-24 Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi
YU52992A YU52992A (sh) 1991-05-24 1992-05-20 Nezasićeni 17 beta-supstituisani 3-karboksi steroidi
MYPI92000863A MY131089A (en) 1991-05-24 1992-05-20 Unsaturated 17(beta)-substituted 3-carboxy steroids
US07/886,574 US5212166A (en) 1991-05-24 1992-05-21 Unsaturated 17β-subsituted 3-carboxy steroids
IL10194792A IL101947A (en) 1991-05-24 1992-05-21 Unsaturated 17beta-substituted 3-carboxy steroids their preparation and pharmaceutical compositions containing them
NZ242850A NZ242850A (en) 1991-05-24 1992-05-21 17-carbamoyl androstane derivatives; medicaments, use, and methods of
EP92108670A EP0517047A1 (en) 1991-05-24 1992-05-22 Unsaturated 17beta-substituted 3-carboxy steroids
CZ93265A CZ281309B6 (cs) 1991-05-24 1992-05-22 Nenasycené 17beta-substituované 3-karboxy-steroidy
MX9202438A MX9202438A (es) 1991-05-24 1992-05-22 Esteroides 3-carboxi insaturados substituidos en la posicion 17 beta, procedimiento para su preparacion y composicion farmaceutica que los contiene.
AU17781/92A AU655280B2 (en) 1991-05-24 1992-05-22 Unsaturated 17beta -substituted 3-carboxy steroids
IDP308292A ID954B (id) 1991-05-24 1992-05-22 STEROID 3-KARBOKSI TERSUBSTITUSI-17β TAK JENUH
ES92910992T ES2106185T3 (es) 1991-05-24 1992-05-22 3-carboxiesteroides 17-beta-sustituidos no saturados.
ZA923758A ZA923758B (en) 1991-05-24 1992-05-22 Unsaturated 17-substituted 3-carboxy steroids
RU93004939A RU2104283C1 (ru) 1991-05-24 1992-05-22 17бета-замещенные 3-карбоксистероиды, способ их получения, фармкомпозиция
PCT/EP1992/001153 WO1992020700A1 (en) 1991-05-24 1992-05-22 UNSATURATED 17β-SUBSTITUTED 3-CARBOXY STEROIDS
HU9300176A HUT64083A (en) 1991-05-24 1992-05-22 Process for producing unsaturated, 17beta-substituted 3-carboxy steroids and pharmaceutical compositions comprising same as active ingredient
JP50978992A JP3226919B2 (ja) 1991-05-24 1992-05-22 不飽和の１７β―置換―３―カルボキシステロイド
DE69221074T DE69221074T2 (de) 1991-05-24 1992-05-22 Ungesatigte 17-beta-substituierte-3-carboxy steroide
TW081104019A TW213467B (it) 1991-05-24 1992-05-22
AT92910992T ATE155792T1 (de) 1991-05-24 1992-05-22 Ungesatigte 17-beta-substituierte-3-carboxy steroide
EP92910992A EP0540717B1 (en) 1991-05-24 1992-05-22 UNSATURATED 17$g(b)-SUBSTITUTED 3-CARBOXY STEROIDS
DK92910992.4T DK0540717T3 (da) 1991-05-24 1992-05-22 Umættede 17 beta-substituerede 3-carboxysteroider
CA002087953A CA2087953A1 (en) 1991-05-24 1992-05-22 Unsaturated 17.beta. -substituted 3-carboxy steroids
CN92103919A CN1035055C (zh) 1991-05-24 1992-05-23 不饱和的17β-取代的3-羧基甾族化合物的制备方法
IE163492A IE921634A1 (en) 1991-05-24 1992-07-01 UNSATURATED 17ß-SUBSTITUTED 3-CARBOXY STEROIDS
NO93930244A NO930244L (no) 1991-05-24 1993-01-25 Umettede 17beta-substituerte 3-karboksysteroider
FI930277A FI930277A7 (fi) 1991-05-24 1993-05-22 Omaettade 17b-substituerade 3-karboxisteroider

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI911432A IT1259419B (it) 1991-05-24 1991-05-24 Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi

Publications (3)

Publication Number Publication Date
ITMI911432A0 ITMI911432A0 (it) 1991-05-24
ITMI911432A1 ITMI911432A1 (it) 1992-11-24
IT1259419B true IT1259419B (it) 1996-03-18

Family

ID=11359980

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI911432A IT1259419B (it) 1991-05-24 1991-05-24 Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi

Country Status (26)

Country Link
US (1) US5212166A (it)
EP (2) EP0540717B1 (it)
JP (1) JP3226919B2 (it)
CN (1) CN1035055C (it)
AT (1) ATE155792T1 (it)
AU (1) AU655280B2 (it)
CA (1) CA2087953A1 (it)
CZ (1) CZ281309B6 (it)
DE (1) DE69221074T2 (it)
DK (1) DK0540717T3 (it)
ES (1) ES2106185T3 (it)
FI (1) FI930277A7 (it)
HU (1) HUT64083A (it)
ID (1) ID954B (it)
IE (1) IE921634A1 (it)
IL (1) IL101947A (it)
IT (1) IT1259419B (it)
MX (1) MX9202438A (it)
MY (1) MY131089A (it)
NO (1) NO930244L (it)
NZ (1) NZ242850A (it)
RU (1) RU2104283C1 (it)
TW (1) TW213467B (it)
WO (1) WO1992020700A1 (it)
YU (1) YU52992A (it)
ZA (1) ZA923758B (it)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618806A (en) * 1992-04-30 1997-04-08 Smithkline Beecham Corporation 17α and 17β-substituted estra-1,3,5(10)-triene-3-carbboxlic acid
US5683995A (en) * 1992-11-18 1997-11-04 Smithkline Beecham Corporation 17 substituted acyl-3-carboxy 3,5-diene steroidals as α-reductase inhibitors
US5641765A (en) * 1992-11-18 1997-06-24 Smithkline Beecham Corporation 17-αand 17-βsubstituted acyl-3-carboxy-3,5-dienes and use in inhibiting 5-α-reductase
EP0717618B1 (en) * 1993-09-03 2002-11-06 Smithkline Beecham Corporation Stabilized tablet formulation
GB9324371D0 (en) * 1993-11-26 1994-01-12 Erba Carlo Spa Side chain fluoro substituted 3-carboxysteroids
US5430157A (en) * 1993-12-13 1995-07-04 Eli Lilly And Company Reduced phenanthrenes
GB9402041D0 (en) * 1994-02-03 1994-03-30 Smithkline Beecham Corp Compounds
US5714480A (en) * 1994-03-31 1998-02-03 Smithkline Beecham Corporation Treating cardiovascular disease with steroidal 5-alpha-reductase inhibitors
WO1995028413A1 (en) * 1994-04-15 1995-10-26 Smithkline Beecham Corporation 17β-SUBSTITUTED 3-CARBOXY STEROIDS THAT INHIBIT 5-α-REDUCTASE
GB9415183D0 (en) * 1994-07-28 1994-09-21 Erba Carlo Spa 3-carboxysteroids with a fluorinated side-chain
US5543417A (en) * 1994-10-21 1996-08-06 Merck & Co., Inc. Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
HUP0203045A3 (en) * 1999-09-22 2004-06-28 Sanofi Aventis Deutschland 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
PL3395372T3 (pl) 2009-02-20 2022-07-25 EnhanX Biopharm Inc. Układ do dostarczania leków na bazie glutationu
CN102458374A (zh) 2009-05-06 2012-05-16 实验室护肤股份有限公司 包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4377584A (en) * 1978-04-13 1983-03-22 Merck & Co., Inc. 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
US5041433A (en) * 1987-04-29 1991-08-20 Smithkline Beecham Corporation 11-keto or hydroxy 3,5-diene steroids as inhibitors of steriod 5-α-reductase
US4910226A (en) * 1987-04-29 1990-03-20 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors
US5032586A (en) * 1989-08-24 1991-07-16 Smithkline Beecham Corporation 7-keto or hydroxy 3,5-diene steroids as inhibitors of steroid 5-alpha reductase
US5091380A (en) * 1990-06-28 1992-02-25 Merck & Co., Inc. N-monosubstituted adamantyl/norbornanyl 17β-carbamides of 3-carboxy-androst-3,5-dienes as testosterone 5α-reductase inhibitors
DK0567271T3 (da) * 1992-04-20 1998-02-16 Sankyo Co Steroidderivater til behandling af prostatahypertrofi, fremgangsmåde til fremstilling heraf og anvendelser heraf

Also Published As

Publication number Publication date
RU2104283C1 (ru) 1998-02-10
CZ26593A3 (en) 1993-11-17
HUT64083A (en) 1993-11-29
IL101947A (en) 1996-01-19
EP0540717A1 (en) 1993-05-12
JPH06500342A (ja) 1994-01-13
MY131089A (en) 2007-07-31
WO1992020700A1 (en) 1992-11-26
DE69221074T2 (de) 1997-11-13
NO930244L (no) 1993-01-27
HU9300176D0 (en) 1993-04-28
IE921634A1 (en) 1992-12-02
CN1035055C (zh) 1997-06-04
ZA923758B (en) 1993-01-27
MX9202438A (es) 1992-11-01
NO930244D0 (no) 1993-01-25
TW213467B (it) 1993-09-21
US5212166A (en) 1993-05-18
CN1067057A (zh) 1992-12-16
ID954B (id) 1996-09-25
ITMI911432A0 (it) 1991-05-24
FI930277A0 (fi) 1993-01-22
ITMI911432A1 (it) 1992-11-24
CA2087953A1 (en) 1992-11-25
EP0517047A1 (en) 1992-12-09
ES2106185T3 (es) 1997-11-01
AU655280B2 (en) 1994-12-15
ATE155792T1 (de) 1997-08-15
JP3226919B2 (ja) 2001-11-12
EP0540717B1 (en) 1997-07-23
FI930277A7 (fi) 1993-01-22
YU52992A (sh) 1995-03-27
DK0540717T3 (da) 1997-08-18
DE69221074D1 (de) 1997-09-04
NZ242850A (en) 1994-01-26
CZ281309B6 (cs) 1996-08-14
AU1778192A (en) 1992-12-30

Similar Documents

Publication Publication Date Title
IT1259419B (it) Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi
ES2159569T3 (es) Procedimiento de preparacion de derivados de sufentanil por adicion de carbeno y aminolisis de 4-piperidona.
CA2160966A1 (fr) Derives de piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE69402043D1 (de) Verfahrenshilfsmittel für gaserzeugende Zusammensetzungen
DK0641343T3 (da) 4-Mercaptoacetylamino-[2]benzazepinon(3)-derivater og anvendelse som enkefalinaseinhibitorer
DE69818049D1 (de) Inhibitoren der alpha4-beta1 vermittelten zelladhäsion
ES2155874T3 (es) Composiciones cosmeticas que contienen acido betulinico.
GR3017656T3 (en) New substituted azetidinones as anti-inflammatory and antidegenerative agents.
MX9304756A (es) 9-[(glicilo substituido)amido]-6-desmetil-6-desoxitetraciclinas, metodo para su produccion y composiciones farmaceuticas que las contienen.
TW225534B (it)
MX9300603A (es) Derivados tiaciclicos de piperidinilo.
BR9509269A (pt) Processo para tratar diabetes
FI953817L (fi) Koostumukset ja menetelmät vetyperoksidin tuhoamiseksi
AU2209500A (en) Inhibitors of alpha4beta1 mediated cell adhesion
PT1023267E (pt) Compostos de piridilo e composicoes farmaceuticas que os contem
HU9601113D0 (en) Delta16 unsaturated c17 heterocyclic steroids useful as steroid c17-20 lyase inhibitors, pharmaceutical compositions containing them and process for their production
BR9611642A (pt) Compostos composição farmacéutica e processo para a preparação de compostos
RU94014256A (ru) Производные 4-хинолиндигидропиридина, смесь их изомеров или отдельные изомеры и их соли
BG100248A (bg) Инхибитори на скваленсинтетаза
PL322763A1 (en) Levobupivacaine and pplication thereof as anelgetic agent for pregnant women
CA2136841A1 (en) Novel Piperidyl Amides, Sulfonamides and Sulfoxamides as Inhibitors of Cholesterol Biosynthesis
MX9603087A (es) Procedimiento para la obtencion de aminocarboniltriazolinonas substituidas.
IL111791A0 (en) Glutaramide derivatives
GR3023044T3 (en) Succinoylamino hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors.
AR003967A1 (es) Epimeros de (22r)-n-(1,1,1-trifluoro-2-fenilprop-2-il)-3-oxo-4-aza-5alfa- androst-1-eno-17beta-carboxamida, un proceso para su preparacion y unacomposicion farmaceutica que los comprenden.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970506